Ad is loading...
AMRN
Price
$0.49
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
96 days until earnings call
IBRX
Price
$5.04
Change
+$0.15 (+3.07%)
Updated
Nov 21 closing price
102 days until earnings call
Ad is loading...

AMRN vs IBRX

Header iconAMRN vs IBRX Comparison
Open Charts AMRN vs IBRXBanner chart's image
Amarin
Price$0.49
Change-$0.00 (-0.00%)
Volume$1.58M
CapitalizationN/A
ImmunityBio
Price$5.04
Change+$0.15 (+3.07%)
Volume$3.37M
CapitalizationN/A
AMRN vs IBRX Comparison Chart
Loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
AMRN vs. IBRX commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRN is a StrongSell and IBRX is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (AMRN: $0.52 vs. IBRX: $5.03)
Brand notoriety: AMRN: Notable vs. IBRX: Not notable
AMRN represents the Pharmaceuticals: Major, while IBRX is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMRN: 178% vs. IBRX: 56%
Market capitalization -- AMRN: $357.53M vs. IBRX: $3.51B
AMRN [@Pharmaceuticals: Major] is valued at $357.53M. IBRX’s [@Biotechnology] market capitalization is $3.51B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRN’s FA Score shows that 0 FA rating(s) are green whileIBRX’s FA Score has 1 green FA rating(s).

  • AMRN’s FA Score: 0 green, 5 red.
  • IBRX’s FA Score: 1 green, 4 red.
According to our system of comparison, IBRX is a better buy in the long-term than AMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRN’s TA Score shows that 4 TA indicator(s) are bullish while IBRX’s TA Score has 5 bullish TA indicator(s).

  • AMRN’s TA Score: 4 bullish, 5 bearish.
  • IBRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IBRX is a better buy in the short-term than AMRN.

Price Growth

AMRN (@Pharmaceuticals: Major) experienced а +0.94% price change this week, while IBRX (@Biotechnology) price change was +3.39% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -2.99%. For the same industry, the average monthly price growth was -8.46%, and the average quarterly price growth was +0.45%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

AMRN is expected to report earnings on Feb 26, 2025.

IBRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-2.99% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IBRX($3.51B) has a higher market cap than AMRN($358M). IBRX YTD gains are higher at: 0.299 vs. AMRN (-39.667). AMRN has higher annual earnings (EBITDA): -50.7M vs. IBRX (-421.03M). AMRN has more cash in the bank: 321M vs. IBRX (130M). AMRN has less debt than IBRX: AMRN (8.74M) vs IBRX (743M). AMRN has higher revenues than IBRX: AMRN (307M) vs IBRX (7.33M).
AMRNIBRXAMRN / IBRX
Capitalization358M3.51B10%
EBITDA-50.7M-421.03M12%
Gain YTD-39.6670.299-13,275%
P/E Ratio67.11N/A-
Revenue307M7.33M4,187%
Total Cash321M130M247%
Total Debt8.74M743M1%
FUNDAMENTALS RATINGS
AMRN vs IBRX: Fundamental Ratings
AMRN
IBRX
OUTLOOK RATING
1..100
5882
VALUATION
overvalued / fair valued / undervalued
1..100
92
Overvalued
4
Undervalued
PROFIT vs RISK RATING
1..100
10087
SMR RATING
1..100
91100
PRICE GROWTH RATING
1..100
8641
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IBRX's Valuation (4) in the Biotechnology industry is significantly better than the same rating for AMRN (92) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew significantly faster than AMRN’s over the last 12 months.

IBRX's Profit vs Risk Rating (87) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew similarly to AMRN’s over the last 12 months.

AMRN's SMR Rating (91) in the Pharmaceuticals Other industry is in the same range as IBRX (100) in the Biotechnology industry. This means that AMRN’s stock grew similarly to IBRX’s over the last 12 months.

IBRX's Price Growth Rating (41) in the Biotechnology industry is somewhat better than the same rating for AMRN (86) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew somewhat faster than AMRN’s over the last 12 months.

IBRX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as AMRN (100) in the Pharmaceuticals Other industry. This means that IBRX’s stock grew similarly to AMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRNIBRX
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
88%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
89%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
72%
Bullish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 1 day ago
71%
Bullish Trend 4 days ago
87%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 10 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
AMRN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
IBRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SPNNX5.940.09
+1.54%
Invesco SteelPath MLP Income R
RREYX30.730.13
+0.42%
Russell Inv Global Real Estate Secs Y
CICCX61.630.18
+0.29%
American Funds Invmt Co of Amer 529C
WFDAX29.38N/A
N/A
Allspring SMID Cap Growth Fund - Cl A
LSNGX20.85N/A
N/A
Loomis Sayles Global Growth N

AMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRN has been loosely correlated with KZR. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRN jumps, then KZR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRN
1D Price
Change %
AMRN100%
+6.17%
KZR - AMRN
56%
Loosely correlated
+1.74%
CNTB - AMRN
55%
Loosely correlated
-5.70%
HRTX - AMRN
44%
Loosely correlated
-5.36%
MGNX - AMRN
44%
Loosely correlated
-2.13%
ALXO - AMRN
43%
Loosely correlated
+6.61%
More

IBRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IBRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if IBRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IBRX
1D Price
Change %
IBRX100%
+3.28%
AXON - IBRX
48%
Loosely correlated
+3.52%
ARRY - IBRX
41%
Loosely correlated
-0.63%
AMRN - IBRX
37%
Loosely correlated
+6.17%
RXRX - IBRX
37%
Loosely correlated
-4.80%
VCYT - IBRX
35%
Loosely correlated
-0.66%
More